Sabitlenmiş Tweet

Happy to share that our seminal work on waixenicin A derivatization is now covered by a provisional patent:
“Waixenicin A Derivatives as Neuroprotective Agents against Hypoxic Ischemic Brain Injury Through TRPM7 Blockade.” @RomoGrp_Baylor
English






























